Conexeu Sciences Inc.
Conexeu Sciences Inc. is listed today as Conexeu Sciences Inc.: market value, financials and filings are on its company page.
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Oct 2026 | $2 M | No. 4 | Under $2 million | equity, options | SEC | |
| Mar 2026 | $2 M | No. 3 | Under $2 million | equity | SEC | |
| Oct 2025 | $3 M | No. 2 | $2 to $10 million | equity | SEC | |
| Apr 2025 | $1 M | No. 1 | Under $2 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Conexeu Sciences Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2026).
SEC Form D · Oct 2026
The industry group it chose in its notices: Biotechnology.
SEC Form D · Oct 2026
That is all the official record says: Conexeu Sciences Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of Conexeu Sciences Inc. are on record.
Investors#
No investor of Conexeu Sciences Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 18 investors.
Largest shareholders today
Institutions holding Conexeu Sciences Inc. shares, as of Sep 30, 2026.
- Vanguard Capital Management LLC$1 M0.91%
- Geode Capital Management, LLC$1 M0.53%
- Renaissance Technologies LLC$0 M0.41%
- Vanguard Fiduciary Trust Co$0 M0.33%
- UBS Group AG$0 M0.18%
- Northern Trust Corp$0 M0.12%
- State Street Corp$0 M0.08%
- Citadel Advisors LLC$0 M0.05%
- Axq Capital, LP$0 M0.05%
- Osaic Holdings, Inc.$0 M0.04%
- Jefferies Financial Group Inc.$0 M0.04%
- Vanguard Global Advisers, LLC$0 M0.02%
- Wells Fargo & Company/mn$0 M0.01%
- Jones Financial Companies Lllp$0 M0.01%
- Jpmorgan Chase & Co$0 M0.00%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Brian Pilcher | Executive officer | Oct 2026 |
| Claudia Chavez-Munoz | Executive officer | Oct 2026 |
| David R Bogart | Executive officer | Oct 2026 |
| Miles Harrison | Executive officer | Oct 2026 |
| Brian Paul Pilcher | Executive officer | Apr 2026 |
| Claudia D Chavez-Munoz | Executive officer | Apr 2026 |
| Miles R Harrison | Executive officer | Apr 2026 |
| Stephen D Inouye | Executive officer | Apr 2026 |
| Brian R Pilcher | Executive officer | Jul 2025 |
| Jeff D Sharpe | Executive officer | Jul 2025 |
| Claudia D Stephen | Executive officer | May 2025 |
| Michael R Wright | Executive officer | May 2025 |
| Aaron Farberg | Director | Oct 2026 |
| Ana Bastiani-Posner | Director | Oct 2026 |
| Andrew Costa | Director | Oct 2026 |
| April Burke | Director | Oct 2026 |
| Jeff Sharpe | Director | Oct 2026 |
| Miles Harrison | Director | Oct 2026 |
| Sebastian Purcell | Director | Oct 2026 |
| Aaron R Farberg | Director | Apr 2026 |
| David R Bogart | Director | Apr 2026 |
| Jeff D Sharpe | Director | Apr 2026 |
| Miles R Harrison | Director | Apr 2026 |
| Sebastian Paul Purcell | Director | Apr 2026 |
| Z Paul Lorenc | Director | Apr 2026 |
| Brian R Pilcher | Director | Jul 2025 |
| Michael R Wright | Director | Jul 2025 |
Went public since 2026. Its SEC number is that of a company listed on a stock exchange.